Expansion of use for two assays gives patients the option to self-collect specimens at home and in the clinic, which may help address gaps in screening
The company is hiring at least 100 sales representatives this year to spread awareness and uptake of its recently FDA-approved Shield test
Experts—including those in genetics and device regulation—say the AvertD assay did not predict risks of abuse ‘any better than chance’
The US Supreme Court decision that recently overturned the Chevron doctrine is influencing potential enactment of new legislation
A lawsuit by a group of herring fishermen upended 40 years of legal precedent regarding how federal agencies interpret statutes